Results 31 to 40 of about 531,069 (346)

How I Treat Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (T-ALL) and T-cell Lymphoblastic Lymphoma in Children.

Blood, 2019
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy that has historically been associated with a very poor prognosis. Nevertheless, despite a lack of incorporation of novel agents, the development of intensified T-ALL focused ...
D. Teachey, D. O’Connor
semanticscholar   +1 more source

Multilineage Lymphoblastic Lymphoma as an Initial Presentation of Mixed Phenotype Acute Leukemia

Case Reports in Hematology, 2023
Mixed phenotype acute leukemia (MPAL) is characterized by leukemic blasts that express markers of multiple lineages. Compared with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), MPAL is considered to have a poor treatment outcome ...
Mako Ikeda, Wataru Nakahara, Mizuki Asako, Yuka Umeki, Yoshiki Matsuoka, Takuya Terakawa, Hitomi Matsunaga, Yuki Iwasa, Riko Saito, Yuki Iwama, Takahiro Matsui, Kazumasa Oka, Shuji Ueda   +12 more
doaj   +1 more source

B-cell Lymphoblastic Lymphoma Presenting as a Sinonasal Mass: A Case Report. [PDF]

Cureus
Vilarello BJ, Jacobson PT, Gudis DA, Overdevest JB.   +3 more
europepmc   +3 more sources

Prognostic significance of DNA cytometry in cutaneous malignant lymphomas. [PDF]

, 1991
The current classification of cutaneous malignant lymphomas (ML) into low-grade and high-grade lymphomas was found to be of limited reproducibility and permitted only a rough prediction about outcome.
Abmayr, Wolfgang, Braun-Falco, Otto, Burg, Günter, Dummer, Reinhard, Eckert, Fritjof, Kaudewitz, Peter, Stolz, Wilhelm, Vogt, Thomas   +7 more
core   +1 more source

Lymphoblastic lymphoma in adults [PDF]

Cancer, 1981
Clinical and cytogenetic studied were done on 12 patients with lymphoblastic lymphoma. The ages of the patients ranged from 17 to 58 years (median, 24.5 years). Males predominated by a ration of 5:1. Ten of the 12 patients had a mediastinal mass at diagnosis; two thirds of the patients had involvement of the bone marrow (3 of 12 patients initially were
R A, Streuli, Y, Kaneko, D, Variakojis, A, Kinnealey, H M, Golomb, J D, Rowley   +5 more
openaire   +2 more sources

The molecular basis of T cell acute lymphoblastic leukemia [PDF]

, 2012
T cell acute lymphoblastic leukemias (T-ALLs) arise from the malignant transformation of hematopoietic progenitors primed toward T cell development, as result of a multistep oncogenic process involving constitutive activation of NOTCH signaling and ...
Adolfo Ferrando, Bash, Bash, Chen, Condorelli, Dube, Fisch, Hagemeijer, Hebert, Ho, Kelliher, Kikuchi, Larson, Lu, McGuire, McGuire, Nagel, Ntziachristos, Ntziachristos, Ono, Pieter Van Vlierberghe, Royer-Pokora, Rubnitz, van Grotel   +23 more
core   +1 more source

B‐cell lymphoblastic lymphoma of the nictitating membrane as the first presenting sign in a 2‐year‐old Springer Spaniel

Clinical Case Reports, 2018
Key Clinical Message B‐cell lymphoblastic lymphoma is an aggressive malignant disease. Necropsy and microscopical examination revealed widespread disease with a high proliferation index.
Frederik Holm, Tommy Hardon, Erik Clasen‐Linde, Lauge Hjorth Mikkelsen, Steffen Heegaard   +4 more
doaj   +1 more source

Blastic transformation of mantle cell lymphoma with B-lymphoblastic features

Human Pathology: Case Reports, 2019
Mantle cell lymphoma is characterized by the presence of the t(11;14)(q13;q32), which is found in more than 95% of cases. We present a case of mantle cell lymphoma with the typical phenotype, which transformed to a blastic morphology with loss of ...
David Cantu, Yuridia Alvarado, Joyce Murata-Collins, Dennis D. Weisenburger   +3 more
doaj   +1 more source

Clinicopathological features of extranodal lymphomas: Kuwait experience [PDF]

, 2004
A total of 935 patients with extranodal non-Hodgkin lymphoma (NHL) diagnosed in the period between January 1985 and December 2000 in Kuwait Cancer Center, serving the whole population of Kuwait, were used to describe the clinicopathological and ...
Bamanikar S, D'Amore F, Ducreux M, F. Sinowatz, Freeman C, Gospodarowicz MK, H. Amanguno, H. Baker, Hauke RJ, J.P. Madda, L. Temmim, Longo DL, Neugut AI, Penn I, Shome DK, Stiller CA, Weisenburger DD, Zeeb H   +17 more
core   +1 more source

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma.

Blood Advances, 2020
Tisagenlecleucel is a CD19 chimeric antigen receptor (CAR) T-cell therapy approved for treatment of pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL) and adults with non-Hodgkin lymphoma (NHL).
M. Pasquini, Zhen-Huan Hu, K. Curran, T. Laetsch, F. Locke, R. Rouce, M. Pulsipher, C. Phillips, A. Keating, M. Frigault, Dana B. Salzberg, S. Jaglowski, Joshua P. Sasine, J. Rosenthal, M. Ghosh, D. Landsburg, S. Margossian, P. Martin, M. Kamdar, P. Hematti, S. Nikiforow, C. Turtle, M. Perales, Patricia Steinert, M. Horowitz, A. Moskop, L. Pacaud, Lan Yi, Raghav Chawla, E. Bleickardt, S. Grupp   +30 more
semanticscholar   +1 more source